048410.KS · 현대바이오
South Korea · RS rating 31 · As of 2026-10-14
| Price | 6,440.00 KRW |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 31 / 22 / 27 / 76 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 33 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (95) |
| EPS growth Q/Q | -118.6% |
| Sales growth Q/Q | +60.3% |
| Distance from 52-week high | +67.8% |
| Market cap (USD) | $498.1M |